Agilent Technologies, Inc. $A Shares Sold by William Blair Investment Management LLC

William Blair Investment Management LLC cut its stake in shares of Agilent Technologies, Inc. (NYSE:A) by 3.8% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 2,063,009 shares of the medical research company’s stock after selling 81,077 shares during the quarter. Agilent Technologies makes up approximately 0.8% of William Blair Investment Management LLC’s portfolio, making the stock its 22nd biggest position. William Blair Investment Management LLC’s holdings in Agilent Technologies were worth $280,714,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also made changes to their positions in A. Board of the Pension Protection Fund acquired a new position in shares of Agilent Technologies during the fourth quarter worth about $27,000. Navalign LLC acquired a new position in shares of Agilent Technologies during the fourth quarter worth about $27,000. Physician Wealth Advisors Inc. grew its position in shares of Agilent Technologies by 490.0% during the third quarter. Physician Wealth Advisors Inc. now owns 236 shares of the medical research company’s stock worth $30,000 after buying an additional 196 shares in the last quarter. Entrust Financial LLC acquired a new position in shares of Agilent Technologies during the fourth quarter worth about $31,000. Finally, Torren Management LLC acquired a new position in shares of Agilent Technologies during the fourth quarter worth about $32,000. 87.41% of the stock is owned by institutional investors and hedge funds.

Agilent Technologies Price Performance

A stock opened at $115.01 on Friday. The business has a 50 day moving average price of $114.77 and a 200 day moving average price of $129.56. The stock has a market cap of $32.50 billion, a price-to-earnings ratio of 25.39, a PEG ratio of 2.42 and a beta of 1.22. Agilent Technologies, Inc. has a fifty-two week low of $107.07 and a fifty-two week high of $160.27. The company has a quick ratio of 1.59, a current ratio of 2.07 and a debt-to-equity ratio of 0.44.

Agilent Technologies (NYSE:A) last issued its quarterly earnings data on Wednesday, February 25th. The medical research company reported $1.36 earnings per share for the quarter, missing analysts’ consensus estimates of $1.37 by ($0.01). Agilent Technologies had a net margin of 18.26% and a return on equity of 24.49%. The firm had revenue of $1.80 billion during the quarter, compared to analysts’ expectations of $1.81 billion. During the same quarter in the prior year, the firm posted $1.31 EPS. Agilent Technologies’s quarterly revenue was up 7.0% compared to the same quarter last year. Agilent Technologies has set its FY 2026 guidance at 5.900-6.040 EPS and its Q2 2026 guidance at 1.390-1.420 EPS. Equities research analysts anticipate that Agilent Technologies, Inc. will post 5.95 earnings per share for the current fiscal year.

Agilent Technologies Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 22nd. Shareholders of record on Tuesday, June 30th will be paid a $0.255 dividend. The ex-dividend date is Tuesday, June 30th. This represents a $1.02 dividend on an annualized basis and a yield of 0.9%. Agilent Technologies’s payout ratio is currently 22.52%.

Wall Street Analysts Forecast Growth

A has been the subject of several recent analyst reports. Barclays decreased their target price on Agilent Technologies from $150.00 to $140.00 and set an “overweight” rating for the company in a research note on Tuesday, April 14th. Morgan Stanley decreased their target price on Agilent Technologies from $180.00 to $160.00 and set an “overweight” rating for the company in a research note on Tuesday, March 3rd. Wall Street Zen cut Agilent Technologies from a “buy” rating to a “hold” rating in a research note on Saturday, May 9th. UBS Group decreased their target price on Agilent Technologies from $180.00 to $165.00 and set a “buy” rating for the company in a research note on Thursday, February 26th. Finally, Wells Fargo & Company decreased their target price on Agilent Technologies from $175.00 to $165.00 and set an “overweight” rating for the company in a research note on Thursday, February 26th. Two analysts have rated the stock with a Strong Buy rating, eleven have given a Buy rating and two have given a Hold rating to the stock. Based on data from MarketBeat.com, Agilent Technologies currently has a consensus rating of “Buy” and an average price target of $163.71.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett?Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.